Metabolism of 25-hydroxyvitamin D3 may explain the U-shaped risk curve for prostate cancer

被引：1
|
作者：
Tuohimaa, P [1 ]
Tenkanen, L
Ahonen, M
Lumme, S
Jellum, E
Hallmans, G
Stattin, P
Harvei, S
Hakulinen, T
Luostarinen, T
Dillner, J
Lehtinen, M
Hakama, M
机构：
[1] Univ Tampere, Sch Med, FIN-33014 Tampere, Finland
[2] Tampere Univ Hosp, Dept Clin Chem, FIN-33521 Tampere, Finland
[3] Helsinki Heart Study, Helsinki, Finland
[4] Natl Hosp Norway, Inst Clin Biochem, Oslo, Norway
[5] Canc Registry Norway, Oslo, Norway
[6] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden
[7] Univ Umea Hosp, Dept Urol, S-90185 Umea, Sweden
[8] Finnish Canc Registry, FIN-00170 Helsinki, Finland
[9] MAS Univ Hosp, Dept Med Microbiol, Malmo, Sweden
[10] Natl Publ Hlth Inst, Helsinki, Finland
[11] Univ Tampere, Inst Publ Hlth, FIN-33101 Tampere, Finland
来源：
INTERNATIONAL JOURNAL OF CANCER | 2004年 / 111卷 / 03期
关键词：
D O I：
10.1002/ijc.20219
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：469 / 469
页数：1
相关论文
共 50 条
  • [1] Enzyme kinetics hypothesis to explain the U-shaped risk curve for prostate cancer vs. 25-hydroxyvitamin D in Nordic countries
    Vieth, R
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2004, 111 (03) : 468 - 468
  • [2] A novel 25-hydroxyvitamin D3 analog for prostate cancer
    Ray, R
    Swamy, N
    Chen, T
    Peleg, S
    Christakos, S
    Weigel, N
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S26 - S26
  • [3] METABOLISM OF 25-HYDROXYVITAMIN D3 BY ALVEOLAR MACROPHAGES IN SARCOIDOSIS
    ADAMS, JS
    SHARMA, OP
    SINGER, FR
    [J]. CLINICAL RESEARCH, 1983, 31 (02): : A499 - A499
  • [4] Mechanistic and pharmacodynamic studies of a 25-hydroxyvitamin D3 derivative in prostate cancer cells
    Lambert, James R.
    Young, Christian D.
    Persons, Kelly S.
    Ray, Rahul
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 361 (01) : 189 - 195
  • [5] Hepatic Transport of 25-Hydroxyvitamin D3 Conjugates: A Mechanism of 25-Hydroxyvitamin D3 Delivery to the Intestinal Tract
    Gao, Chunying
    Liao, Michael Z.
    Han, Lyrialle W.
    Thummel, Kenneth E.
    Mao, Qingcheng
    [J]. DRUG METABOLISM AND DISPOSITION, 2018, 46 (05) : 581 - 591
  • [6] Critique of the U-shaped serum 25-hydroxyvitamin D level-disease response relation
    Grant, William B.
    [J]. DERMATO-ENDOCRINOLOGY, 2009, 1 (06) : 289 - 293
  • [7] Validation of the 24,25-dihydroxyvitamin D3 to 25-hydroxyvitamin D3 ratio as a biomarker of 25-hydroxyvitamin D3 clearance
    Hsu, Simon
    Zelnick, Leila R.
    Lin, Yvonne S.
    Best, Cora M.
    Kestenbaum, Bryan R.
    Thummel, Kenneth E.
    Hoofnagle, Andrew N.
    de Boer, Ian H.
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2022, 217
  • [8] METABOLISM OF 25-HYDROXYVITAMIN D3 BY RAT-KIDNEY MICROSOMES
    THIERRYPALMER, M
    GRAY, TK
    WILLIAMS, ME
    TALMAGE, RV
    [J]. CALCIFIED TISSUE INTERNATIONAL, 1983, 35 (4-5) : 704 - 704
  • [9] Chemopreventive efficacy of 25-hydroxyvitamin D3 in colon cancer
    Murillo, Genoveva
    Matusiak, Damien
    Benya, Richard V.
    Mehta, Rajendra G.
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2007, 103 (3-5): : 763 - 767
  • [10] Vitamin D and Pancreatic Cancer Risk - No U-Shaped Curve
    Baggerly, Leo L.
    Garland, Cedric F.
    [J]. ANTICANCER RESEARCH, 2012, 32 (03) : 981 - 984
12345